CompletedNot Applicable

Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection

United States10 participantsStarted 2013-07-18

Plain-language summary

The purpose of this pilot study is to find out if adding triamcinolone (steroid) injection at the participant's initial esophagogastroduodenoscopy (EGD) procedure will improve the opening of their esophagus and decrease the need for repeat dilations.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who present for EGD with dilation for dysphagia symptoms thought secondary to either radiation-induced stricture or anastomotic stricture based on history Exclusion Criteria: * Inability to consent for the procedure * Known coagulopathy \[International Normalized Ratio (INR) \>1.5, Platelets \<75 K\] * Endoscopic finding of a stricture that is not caused by either radiation or anastomotic narrowing * Nasopharyngeal strictures

What they're measuring

Number of Visits to Receive Esophageal Dilation During the 12 Month Follow-up Period

Timeframe: 12 months

Trial details

NCT IDNCT01873573

SponsorH. Lee Moffitt Cancer Center and Research Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-08-25

View on ClinicalTrials.gov More Dysphagia trials